These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7492924)

  • 61. Alteration of the redox state with reactive oxygen species for 5-fluorouracil-induced oral mucositis in hamsters.
    Yoshino F; Yoshida A; Nakajima A; Wada-Takahashi S; Takahashi SS; Lee MC
    PLoS One; 2013; 8(12):e82834. PubMed ID: 24376587
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Topical application of royal jelly has a healing effect for 5-fluorouracil-induced experimental oral mucositis in hamsters.
    Suemaru K; Cui R; Li B; Watanabe S; Okihara K; Hashimoto K; Yamada H; Araki H
    Methods Find Exp Clin Pharmacol; 2008 Mar; 30(2):103-6. PubMed ID: 18560624
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.
    Vadhan-Raj S; Trent J; Patel S; Zhou X; Johnson MM; Araujo D; Ludwig JA; O'Roark S; Gillenwater AM; Bueso-Ramos C; El-Naggar AK; Benjamin RS
    Ann Intern Med; 2010 Sep; 153(6):358-67. PubMed ID: 20855800
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis.
    Wymenga AN; van der Graaf WT; Hofstra LS; Spijkervet FK; Timens W; Timmer-Bosscha H; Sluiter WJ; van Buuren AH; Mulder NH; de Vries EG
    Clin Cancer Res; 1999 Jun; 5(6):1363-8. PubMed ID: 10389920
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Healing action of topical chamomile on 5-fluoracil induced oral mucositis in hamster.
    Pavesi VC; Lopez TC; Martins MA; Sant'Ana Filho M; Bussadori SK; Fernandes KP; Mesquita-Ferrari RA; Martins MD
    Support Care Cancer; 2011 May; 19(5):639-46. PubMed ID: 20424869
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil.
    McCarthy GM; Awde JD; Ghandi H; Vincent M; Kocha WI
    Oral Oncol; 1998 Nov; 34(6):484-90. PubMed ID: 9930359
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical, biochemical and histological study of the effect of antimicrobial photodynamic therapy on oral mucositis induced by 5-fluorouracil in hamsters.
    Cruz Éde P; Campos L; Pereira Fda S; Magliano GC; Benites BM; Arana-Chavez VE; Ballester RY; Simões A
    Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):298-309. PubMed ID: 25612464
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The chromatographic constitution of andiroba oil and his healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option.
    Gomes JT; Wanzeler AMV; Júnior SMA; Soares RHFC; Oliveira CP; Rodrigues EM; Soares BM; Alcantara DDFA; Burbano RMR; Tuji FM
    Oncotarget; 2023 Jan; 14():23-39. PubMed ID: 36634224
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of the route of leukotrienes in an experimental model of oral mucositis induced by 5-fluorouracil 1.
    Silva VCD; Leitão RFC; Brito GAC; Martins CDS; Freire GE; Aragão KS; Wanderley CWS; Freitas MR
    Acta Cir Bras; 2017 Sep; 32(9):712-725. PubMed ID: 29019589
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-fluorouracil in a mouse mucositis model.
    Wu Z; Han X; Qin S; Zheng Q; Wang Z; Xiang D; Zhang J; Lu H; Wu M; Zhu S; Yu Y; Wang Y; Han W
    Biomed Pharmacother; 2010 Nov; 64(9):589-93. PubMed ID: 20888173
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Azilsartan reduced TNF-α and IL-1β levels, increased IL-10 levels and upregulated VEGF, FGF, KGF, and TGF-α in an oral mucositis model.
    de Araújo AA; Varela H; de Medeiros CA; de Castro Brito GA; de Lima KC; de Moura LM; de Araújo Júnior RF
    PLoS One; 2015; 10(2):e0116799. PubMed ID: 25689279
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer.
    Cerchietti LC; Navigante AH; Lutteral MA; Castro MA; Kirchuk R; Bonomi M; Cabalar ME; Roth B; Negretti G; Sheinker B; Uchima P
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1330-7. PubMed ID: 16765532
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of ceramide inhibition on experimental radiation-induced oral mucositis.
    Hwang D; Popat R; Bragdon C; O'Donnell KE; Sonis ST
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Sep; 100(3):321-9. PubMed ID: 16122660
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy.
    Peterson DE; Barker NP; Akhmadullina LI; Rodionova I; Sherman NZ; Davidenko IS; Rakovskaya GN; Gotovkin EA; Shinkarev SA; Kopp MV; Kulikov EP; Moiseyenko VM; Gertner JM; Firsov I; Tuleneva T; Yarosh A; Woon CW
    J Clin Oncol; 2009 Sep; 27(26):4333-8. PubMed ID: 19636011
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Wound healing process with different photobiomodulation therapy protocols to treat 5-FU-induced oral mucositis in hamsters.
    Cotomacio CC; Calarga CC; Yshikawa BK; Arana-Chavez VE; Simões A
    Arch Oral Biol; 2021 Nov; 131():105250. PubMed ID: 34482219
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy.
    Limaye SA; Haddad RI; Cilli F; Sonis ST; Colevas AD; Brennan MT; Hu KS; Murphy BA
    Cancer; 2013 Dec; 119(24):4268-76. PubMed ID: 24114811
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial.
    Cowen D; Tardieu C; Schubert M; Peterson D; Resbeut M; Faucher C; Franquin JC
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):697-703. PubMed ID: 9240635
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative assessment of the therapeutic effects of the topical and systemic forms of Hypericum perforatum extract on induced oral mucositis in golden hamsters.
    Tanideh N; Namazi F; Andisheh Tadbir A; Ebrahimi H; Koohi-Hosseinabadi O
    Int J Oral Maxillofac Surg; 2014 Oct; 43(10):1286-92. PubMed ID: 24948410
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of basic fibroblast growth factor on radiation-induced oral mucositis in male Syrian hamsters.
    Sumikawa S; Watanabe S; Tanaka M; Tanaka A; Araki H
    Int J Radiat Biol; 2017 Dec; 93(12):1343-1349. PubMed ID: 29034752
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression and degranulation of mast cells in laser photobiomodulated mucositis chemo-induced: pilot study in hamsters.
    de Santana Cerqueira N; Vitória LA; da Silva VP; Rodriguez TT; Cangussu MCT; Ramalho LMP
    Lasers Med Sci; 2023 Jan; 38(1):31. PubMed ID: 36595054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.